Form 4: Definitive Healthcare CEO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Definitive Healthcare CEO Kevin Coop disposed of 28,236 shares of Class A Common Stock to cover tax obligations related to restricted stock unit vesting.

Summary

  • Kevin Coop, the Chief Executive Officer and a Director of Definitive Healthcare Corp. (DH), reported a transaction involving Class A Common Stock.
  • The transaction occurred on January 1, 2026, and involved the disposition of 28,236 shares.
  • The shares were disposed of at a price of $2.87 per share.
  • This disposition was categorized as an 'F' transaction code, indicating the withholding of shares by the Issuer to satisfy tax withholding obligations.
  • The tax obligations are in connection with the vesting and settlement of previously reported restricted stock units.
  • Following this transaction, Kevin Coop beneficially owns 3,556,552 shares of Class A Common Stock directly.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale plan.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary sale to cover tax obligations upon RSU vesting, which is a routine event and does not reflect a change in management's outlook on the company. It is therefore considered neutral.

Positives

  • The transaction was a non-discretionary sale to cover tax obligations, which is a routine event for executives and not indicative of a lack of confidence in the company.
  • The transaction was executed under a Rule 10b5-1(c) plan, demonstrating a pre-scheduled and compliant approach to insider stock sales.

Negatives

  • The CEO's direct beneficial ownership of Class A Common Stock decreased by 28,236 shares as a result of the tax withholding.

Industry Context

This insider transaction is a routine event for executives in publicly traded companies, particularly when restricted stock units (RSUs) vest. It does not inherently reflect on broader industry trends or competitive landscape but rather on individual executive compensation and tax planning.

Stakeholder Impact

  • Shareholders: The CEO's direct beneficial ownership of Class A Common Stock decreased by 28,236 shares, which is a minor reduction relative to his total holdings of 3,556,552 shares.

Key Dates

DateDescription
01/01/2026Date of transaction for the disposition of Class A Common Stock.
01/05/2026Date the Form 4 was signed by the Attorney-in-Fact for Kevin Coop.

Recommendation

hold

The reported transaction is a non-discretionary sale of shares to satisfy tax withholding obligations upon the vesting of restricted stock units. This is a routine event for executives and does not indicate a change in the company's fundamentals or management's confidence, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Definitive Healthcare, DH, Kevin Coop, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CEO, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.